Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program
Latest Information Update: 14 Oct 2021
At a glance
- Drugs Brolucizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 06 Oct 2021 New trial record